KYMR
Price
$45.79
Change
-$0.06 (-0.13%)
Updated
Jul 25 closing price
Capitalization
3.21B
5 days until earnings call
VERA
Price
$21.81
Change
-$0.07 (-0.32%)
Updated
Jul 25 closing price
Capitalization
1.39B
11 days until earnings call
Interact to see
Advertisement

KYMR vs VERA

Header iconKYMR vs VERA Comparison
Open Charts KYMR vs VERABanner chart's image
Kymera Therapeutics
Price$45.79
Change-$0.06 (-0.13%)
Volume$362.48K
Capitalization3.21B
Vera Therapeutics
Price$21.81
Change-$0.07 (-0.32%)
Volume$946.35K
Capitalization1.39B
KYMR vs VERA Comparison Chart in %
Loading...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KYMR vs. VERA commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KYMR is a Hold and VERA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (KYMR: $45.79 vs. VERA: $21.81)
Brand notoriety: KYMR and VERA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KYMR: 38% vs. VERA: 51%
Market capitalization -- KYMR: $3.21B vs. VERA: $1.39B
KYMR [@Biotechnology] is valued at $3.21B. VERA’s [@Biotechnology] market capitalization is $1.39B. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KYMR’s FA Score shows that 0 FA rating(s) are green whileVERA’s FA Score has 1 green FA rating(s).

  • KYMR’s FA Score: 0 green, 5 red.
  • VERA’s FA Score: 1 green, 4 red.
According to our system of comparison, both KYMR and VERA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KYMR’s TA Score shows that 3 TA indicator(s) are bullish while VERA’s TA Score has 5 bullish TA indicator(s).

  • KYMR’s TA Score: 3 bullish, 6 bearish.
  • VERA’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, VERA is a better buy in the short-term than KYMR.

Price Growth

KYMR (@Biotechnology) experienced а -0.84% price change this week, while VERA (@Biotechnology) price change was -5.38% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.60%. For the same industry, the average monthly price growth was +17.32%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

KYMR is expected to report earnings on Aug 01, 2025.

VERA is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+7.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYMR($3.21B) has a higher market cap than VERA($1.39B). KYMR YTD gains are higher at: 13.821 vs. VERA (-48.428). VERA has higher annual earnings (EBITDA): -167.77M vs. KYMR (-232.67M). VERA has more cash in the bank: 590M vs. KYMR (463M). VERA has less debt than KYMR: VERA (54.5M) vs KYMR (86.3M). KYMR has higher revenues than VERA: KYMR (58.9M) vs VERA (0).
KYMRVERAKYMR / VERA
Capitalization3.21B1.39B231%
EBITDA-232.67M-167.77M139%
Gain YTD13.821-48.428-29%
P/E RatioN/AN/A-
Revenue58.9M0-
Total Cash463M590M78%
Total Debt86.3M54.5M158%
TECHNICAL ANALYSIS
Technical Analysis
KYMRVERA
RSI
ODDS (%)
Bearish Trend 3 days ago
84%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
89%
Momentum
ODDS (%)
Bullish Trend 3 days ago
86%
Bearish Trend 3 days ago
83%
MACD
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 3 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
83%
Advances
ODDS (%)
Bullish Trend 5 days ago
85%
Bullish Trend 11 days ago
86%
Declines
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
82%
Bullish Trend 3 days ago
82%
Aroon
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VMGMX126.211.13
+0.90%
Vanguard Mid-Cap Growth Index Admiral
RSDGX22.140.17
+0.77%
Victory RS Select Growth A
STFFX50.340.32
+0.64%
Allspring Large Cap Growth R6
PJSQX23.820.09
+0.38%
PGIM Jennison Small Company R6
RGCIX10.07N/A
N/A
Russell Inv Global Infrastructure C

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been closely correlated with NRIX. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if KYMR jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
-0.13%
NRIX - KYMR
67%
Closely correlated
-0.09%
VERA - KYMR
59%
Loosely correlated
-0.32%
CGON - KYMR
57%
Loosely correlated
-0.15%
CCCC - KYMR
54%
Loosely correlated
-1.31%
LYRA - KYMR
54%
Loosely correlated
-2.33%
More

VERA and

Correlation & Price change

A.I.dvisor indicates that over the last year, VERA has been loosely correlated with KYMR. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if VERA jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VERA
1D Price
Change %
VERA100%
-0.32%
KYMR - VERA
59%
Loosely correlated
-0.13%
LYRA - VERA
54%
Loosely correlated
-2.33%
OPORF - VERA
50%
Loosely correlated
N/A
BPMC - VERA
46%
Loosely correlated
N/A
BNTX - VERA
40%
Loosely correlated
+0.65%
More